| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/30/2002 | CN1333242A Novel polypeptide--human tropomyosin 25.08 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333241A Novel polypeptide--human signalling related protein 20.24 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333240A Novel polypeptide--human gene pleiotropic regulator 1 (PLRG1) protein 10.01 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333239A Novel polypeptide--human III type major histocompatibility protein loomplex 61 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333238A Novel polypeptide--human muscle development related protein (LRRFIP1) 10.89 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333237A Novel polypeptide--human Kruppel zinc finger related protein 70.84 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333236A Novel polypeptide--human large protein 47 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333235A Novel polypeptide-oncoprotein 11.66 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333234A Novel polypeptide--gene product 8.69 conjugated with CpG island of VIII factor gene and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333233A Novel polypeptide--enkaryotic transcription factor 17.38 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333232A Novel polypeptide--dead effector structure domain DNA conjugated protein 10.89 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333231A Novel polypeptide--tight junction protein Z0-1-10.01 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333230A Novel polypeptide--bone marrow translocation gene related protein 12.32 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333229A Novel polypeptide--TEGT protein 42.13 and polynucleotide for encoding this polypeptide |
| 01/30/2002 | CN1333228A Novel polypeptide--eukaryotic releasing factor 110.67 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333227A Novel polypeptide-cell surface protein TAPA-123.32 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333226A Novel polypeptide--butyrophilin 52.91 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333225A Novel polypeptide--oligodendrocyte-myelin glucoprotein 9.68 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333224A Novel polypeptide--LLRep3 ribosomal protein 11.88 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333223A Novel polypeptide--chromatin agregation protein 70 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333222A Novel polypeptide--degeorge syndrome key area 2-16.06 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333221A Novel polypeptide--human ubiquitin protein stable protein 9.02 and polynucleotide for coding said polypeptide |
| 01/30/2002 | CN1333220A Novel polypeptide--chromosome translocation related hot spot conjugated protein 9.79 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333219A Novel polypeptide--NAd-dependent 2-hydroxy acid dehydrogenase family protein 29.15 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333218A Novel polypeptide--zinc finger protein 12.76 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333217A Novel polypeptide--pedalcalix protein similar pretein 9.46 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333216A Novel polypeptide--ring finger protein 151 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333215A Novel polypeptide--developmental regulation related protein 10.45 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333214A Novel polypeptide-four times membrane-spanning protein 14,19 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333213A Novel polypeptide-cell signaling protein MyD 24.09 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1078613C Spinacia and betaine aldehyde dehydrogenase gene and method for raising resistance to salt of plant |
| 01/29/2002 | US6342660 DNA construct containing Bacillus thuringiensis gene and plants containing it |
| 01/29/2002 | US6342658 Fatty acid desaturases and mutant sequences thereof |
| 01/29/2002 | US6342657 Expression cassettes and vectors for plant transformation; molecular hybridization; genetic engineering; activating site-specific recombination system in early embryo; promoter linked to recombinase gene |
| 01/29/2002 | US6342656 Regulation of source-sink relationships and responses to stress conditions in plants |
| 01/29/2002 | US6342655 Plants resistant to WT strains of cucumber mosaic virus |
| 01/29/2002 | US6342654 Gene expression promoter; eliciting hypersensitive response |
| 01/29/2002 | US6342596 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/29/2002 | US6342595 Gene expression of jun n-terminal kinase proteins; antiproliferative agents |
| 01/29/2002 | US6342594 Determination of metastatic potential of cancer cells in test samples |
| 01/29/2002 | US6342588 Conjugating biotin-tyramine label to proteins, peptides, or ligands comprising specific binding pair by use of hydrogen peroxidase enzyme; gene expression from modified nucleic acid; genetic engineering |
| 01/29/2002 | US6342585 Method of activating denatured protein |
| 01/29/2002 | US6342584 Antiproliferative, anticarcinogenic, antitumor, antiinflammatory, and antimetastasis agents; diabetes, restenosis, rheumatoid arthritis treatment; genetic engineering |
| 01/29/2002 | US6342581 Genetic engineering and expression of polynucleotides and polypeptides; vectors, cells, antibodies for diagnosis and disease treatment |
| 01/29/2002 | US6342392 Isolation of human and murine wild-type int6 gene cdna; cancer diagnosis; gene and immunotherapy; vaccines; gene expression |
| 01/29/2002 | US6342390 Integration of dna into chromosome of cell; does not generate virus particles; genetic expression and engineering |
| 01/29/2002 | US6342387 Lysing biological sample and forming dna bound carrier in solution with salt and cationic surfactant; separation, dissociation and recovering dna from carrier; cancer and genetic disorder diagnosis; purification; high yield |
| 01/29/2002 | US6342383 Reverse transcriptase activity; endogenous retroviruses |
| 01/29/2002 | US6342382 Purified nucleic acid; complementarity; washing follow hybridization; genetic engineering and expression |
| 01/29/2002 | US6342380 Germacrene C synthase gene of Lycopersicon esculentum |
| 01/29/2002 | US6342379 Detection of transmembrane potentials by optical methods |
| 01/29/2002 | US6342376 Two-color differential display as a method for detecting regulated genes |
| 01/29/2002 | US6342375 Modified methylotrophic Pichia pastoris yeast which secretes human growth hormone |
| 01/29/2002 | US6342374 Human collagenase inhibitor, recombinant vector system for using same and recombinant-DNA method for the manufacture of same |
| 01/29/2002 | US6342372 Culture to form protein using nutrients, isolation, culture of cells for expression of recombitant protein |
| 01/29/2002 | US6342370 Amino acid seqences and polynucleotides |
| 01/29/2002 | US6342368 WD-40-derived peptides and uses thereof |
| 01/29/2002 | US6342363 Death domain containing receptor 4 nucleic acids and methods |
| 01/29/2002 | US6342360 Dopamine receptors and genes |
| 01/29/2002 | US6342357 An isolated mutant dna; for diagnosis and therapy for cardiovascular disorders characterized by prolonation of the qt interval on electrocardiogram and the presence of syncope, seizures and sudden death |
| 01/29/2002 | US6342356 Methods and regents for identifying synthetic genetic elements |
| 01/29/2002 | US6342354 Determining chromosomal region positioning during interphase by transforming cells with a linear dna vector having two ends; where one end is capable of homologous recombination, the second end is capable of illegitimate integration |
| 01/29/2002 | US6342352 Method of detecting shigella and shigella mxiM DNA |
| 01/29/2002 | US6342351 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 01/29/2002 | US6342350 Alpha-2-macroglobulin diagnostic test |
| 01/29/2002 | US6342345 A low affinity reporter molecule, that associats with a second reporter to generate an enzymatic active complex; linked to a binding moiety; detection binding interactions within cells during developmental stages and differentiation |
| 01/29/2002 | US6342234 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 01/29/2002 | US6342233 Pseudomonas treatment composition and method |
| 01/29/2002 | US6342229 Used in assays, in diagnostics and in immunotherap y and immunoprophylaxis |
| 01/29/2002 | US6342224 For prophylaxis and therapy of human papilloma induced tumours |
| 01/29/2002 | US6342223 Conjugate vaccine capable of conferring host immunity to an infection by group b streptococcus which comprises polysaccharide conjugated to protein |
| 01/29/2002 | US6342222 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 01/29/2002 | US6342221 Antibody conjugate compositions for selectively inhibiting VEGF |
| 01/29/2002 | US6342220 Agonist antibodies |
| 01/29/2002 | US6342219 As anti-angiogenic and in tumor therapy |
| 01/29/2002 | US6342216 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 01/29/2002 | US6342215 Mutant microorganism having reduced adaptation to particular environment; avirulent pathogens for vaccines |
| 01/29/2002 | US6342214 Method for viral vector delivery |
| 01/29/2002 | US6342161 Method for high resolution liquid chromatographic separation of double-stranded DNA |
| 01/29/2002 | CA2226714C Method for identifying the attenuated varicella virus oka strain or a strain derived therefrom |
| 01/29/2002 | CA2223769C Method of treatment for asthma |
| 01/29/2002 | CA2222909C Detection and quantification of one or more nucleotide sequence target analytes in a sample using spatially localized target analyte replication |
| 01/29/2002 | CA2219891C Methods and reagents for combined pcr amplification and hybridization probing assay |
| 01/29/2002 | CA2174745C Keto group introducing enzyme, dna coding for the same, and process for producing ketocarotenoids |
| 01/29/2002 | CA2158575C Chlamydia vaccine and process |
| 01/29/2002 | CA2155330C Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/29/2002 | CA2040896C Double receptor polynucleotide assay method |
| 01/28/2002 | CA2353115A1 Hvd1 gene induced by salt stress |
| 01/28/2002 | CA2352645A1 Compositions for dna transfection |
| 01/28/2002 | CA2315289A1 Plant promoter isolated from douglas-fir 2s seed storage protein gene |
| 01/24/2002 | WO2002007100A1 Method, system and program of indicating expression phenomenon of biosystem |
| 01/24/2002 | WO2002006834A2 Nested sorting and high throughput screening |
| 01/24/2002 | WO2002006790A1 Increased separation efficiency via controlled aggregation of magnetic nanoparticles |
| 01/24/2002 | WO2002006537A2 Methods of identifying renal protective factors |
| 01/24/2002 | WO2002006536A2 Methods and compositions for perioperative genomic profiling |
| 01/24/2002 | WO2002006533A2 Single primer pcr amplification of rna |
| 01/24/2002 | WO2002006532A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 01/24/2002 | WO2002006529A2 Detection and treatment of polycystic kidney disease |
| 01/24/2002 | WO2002006528A1 Method and apparatus for the automated generation of nucleic acid ligands |
| 01/24/2002 | WO2002006525A2 Obesity associated biallelic marker maps |